Valeant Pharmaceuticals (VRX): More Bad News Hits Hard

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) Valeant Pharmaceuticals has been having a rough time in the market since Thursday of last week as federal investigators made the decision to look into the company. Since then, VRX produced a stronger than expected earnings report, but it wasn’t enough to excite investors. Now, an analyst has made … Read more

Valeant Pharmaceuticals (VRX) Continues Falling After Strong Earnings Report

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) Valeant Pharmaceuticals has had a rough time in the market over the past few trading sessions, and that hard time is continuing today. Even after producing solid earnings, the company can’t seem to get past the major blow that was dealt last week. Today, we’ll talk about the big … Read more

Biotech Stock News (VRX) (ESPR) (REGN) (AMGN) (SRPT)

Valeant Pharmaceuticals (NYSE:VRX) On September 28, 2015 shares of Valeant closed the day down approximately 16% after congressional democrats announced that they would file a subpoena to look into the matter about the company’s high priced drugs. The two democrats that filed for this subpoena are Elijah Cummings and Bernie Sanders. More specifically these Democratic … Read more

Biotechs Making A Comeback: Novavax (NVAX), Horizon Pharma (HZNP), Opexa Therapeutics (OPXA), Gilead Sciences (GILD), Valeant Pharmaceuticals (VRX)

The US stock market has taken a beating recently, with biotechs taking the brunt of the punishment after comments made by Hillary Clinton. However, today is a relatively green day across the board, and there are several biotech stocks that are making a comeback. Here are 5 biotechs that are making a comeback that’s well … Read more